Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. (Q33595649)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. |
scientific article |
Statements
1 reference
Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. (English)
1 reference
A F List
1 reference
J M Bennett
1 reference
M A Sekeres
1 reference
B Skikne
1 reference
T Fu
1 reference
J M Shammo
1 reference
S D Nimer
1 reference
R D Knight
1 reference
A Giagounidis
1 reference
MDS-003 Study Investigators
1 reference
22 October 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference